Keywords
acute pancreatitis, endoscopic retrograde cholangiopancreatography, Wirsung’s duct, Oddi’s sphincter, endoscopic papillosphincterotomy, proton pump inhibitors, premedication retrograde cholangiopancreatography
How to Cite
Aminov, I. H., Churkin, M. V., Plotnikova, E. J., Podoluzhny, V. I., KrasnovK. А., & Krasnov, O. A. (2016). Comparative analysis of methods of prevention of drug- ERCP-induced pancreatitis. Herald of Pancreatic Club, 32(3), 49-56. https://doi.org/10.33149/vkp.2016.03.07
Abstract views: 145 PDF Downloads: 137 PDF Downloads: 161
Abstract
Endoscopic retrograde cholangiopancreatography (ERСP) is an invasive procedure that is performed for diagnosis and treatment of pancreatic and biliary diseases. Approximately in 5–40% of cases the procedure itself causes side effects. The most common complication of post-ERСP is acute pancreatitis. Identifying risk factors and groups is a necessary measure of prevention of pancreatitis after ERСP. This paper provides an overview of research on drug prevention of post- ERСP acute pancreatitis. Early detection of complications and early intervention can minimize the morbidity and mortality associated with this complication. The original scheme for the prevention of this complication is proposed. This set of expanded premedication allowed significantly reduce the incidence of ERСP -induced pancreatitis.
References
1. Дискуссионные вопросы хирургических вмешательств на большом сосочке двенадцатиперстной кишки / Лебедев С. В., Еремеев А. Г, Балалыкин А. С. [и др.] // Анналы хирургической гепатологии. – 2007. – № 4. – С. 45–53.
2. Ильченко А. А. Желчнокаменная болезнь / А. А. Ильченко. – М. :Анахарсис, 2004. – 200 с.
3. Ильченко А. А. Эндоскопическая ретроградная холангиопанкреатико-графия: возможна ли эффективная профилактика ЭРХПГ-индуцированного панкреатита / А. А. Ильченко// Экспериментальная и клиническая гастроэнтерология. – 2008. – № 3. – С. 62–71.
4. Лосев С. В. Применение «Oктреотида» для профилактики панкреатита при проведении ЭРХПГ [Электронный ресурс] / С. В. Лосев, В. В. Феденко. – Электрон. текстовые дан. – Режим доступа: http://octreotide.Pharm-sintez.ru/issue/octr107.htm.
5. Манцеров М. П. Реактивный панкреатит после эндоскопических манипуляций на большом дуоденальном сосочке / Манцеров М. П., Мороз Е. В. // Рос. журн. Гастроэнтерол., гепатол., колопроктол. – 2007. – Т. XVII, № 3. – С. 14–23.
6. Ханевич М. Д. Транспапиллярные методы лечения механической желтухи / М. Д. Ханевич, А. М. Гробовый // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. – 2005. – № 3. – С. 57–61.
7. Эндоскопическая ретроградная холангиопанкреатография. Стандарт проведения / Щербаков П. Л., Парфенов А. И., Ильченко А. А. [и др.] // Экспериментальная и клиническая гастроэнтерология. – 2009. – № 3. – С. 150–155.
8. Banks P. A. Practice Parameters Committee of the American College of Gastroenterology. Practice Guidelines in Acute Pancreatitis / P. A. Banks, M. L. Freeman // Am. J. Gastroenterol. – 2006. – Vo. 101. – Р. 2379–2400.
9. Banks P. A. Practice Parameters Committee of the American College of Gastroenterology. Practice Guidelines in Acute Pancreatitis / P. A. Banks, M. L. Freeman // Am. J. Gastroenterol. – 2006. – Vol. 101. – Р. 2379–2400.
10. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial / Arvanitidis D., Anagnostopoulos G.K., Giannopoulos D. [et al.] // J Gastroenterol Hepatol. – 2004. – Vol. 19. – Р. 278–282.
11. Chen S.Y. Ulinastatin in the treatment of acute pancreatitis : a multicenter clinical trial / Chen S.Y., Wang J.Y. // Chin J Dig Dis. – 2002. – Vol. 3. – Р. 70–75.
12. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis : a prospective, randomized trial / Ueki T., Otani K., Kawamoto K. [et al.] // J Gastroenterol. – 2007. – Vol. 42. – Р. 161–167.
13. Complications of endoscopic sphincterotomy: Can heparin prevent acute pancreatitis after ERCP? / Rabenstein T., Roggenbuck S., Framke B. [et al.] // Gastrointest Endosc. – 2002. – Vol. 55. – Р. 476–483.
14. Complications of ERCP by the American Society for Gastrointestinal Endoscopy // Gastrointestinal Endoscopy. – 2012. – Vol. 75, No 3. – Р. 467–472.
15. De Palma G. D. Use of corticosteriods in the prevention of post-ERCP pancreatitis : results of a controlled prospective study / G. D. De Palma, C. Catanzano // Am. J. Gastroenterol. – 1999. – Vol. 94. – Р. 982-5.
16. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography / B. Murray, R. Carter, C. Imrie [et al.] // Gastroenterology. – 2003. – Vol. 124. – Р. 1786–1791.
17. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis : a randomized, prospective, multicenter study / S. Sherman, U. Blaut, J. L. Watkins [et al.] // Gastrointest Endosc. – 2003. – Vol. 58. – Р. 23–29.
18. Donnellan F. Prevention of Post-ERCP Pancreatitis / F. Donnellan, M. F. Byrne. // Gastroenterology Research and Practice. – 2012. – Article ID 796751. – 12 p.
19. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes / K. Gottlieb, S. Sherman, J. Pezzi [et al.] // Am. J. Gastroenterol. – 1996. – Vol. 91. – Р. 1553–1561.
20. Effect of calcitonin on the serum amylase levels after endoscopic retrograde cholangiopancreatography / Odes H.S., Novis B.N., Barbezat G.O., Bank S. // Digestion. – 1977. – Vol. 16. – Р. 180–184.
21. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia : a multicenter, placebo-controlled, randomized clinical trial / Li Z.S., Pan X., Zhang W.J. [et al.] // Am J Gastroenterol. – 2006. – Vol. 102. – Р. 46–51.
22. Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis / Messori A., Rampazzo R., Scroccaro G. [et al.] // Dig Dis Sci. – 1995. – Vol. 40. – Р. 734–738.
23. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique / E. Elton, D. A. Howell, W. G. Parsons [et al.] // Gastrointest. Endosc. – 1998. – Vol. 47. – Р. 240–249.
24. Freeman M. L. Prevention of post-ERCP pancreatitis : a comprehensive review / M. L. Freeman, N. M. Guda // Gastrointest Endosc. – 2004. – Vol. 59. – Р. 845–864.
25. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group / Cavallini G., Tittobello A., Frulloni L. [et al.] // N Engl J Med. – 1996. – Vol. 335. – Р. 919–923.
26. Guidewire Cannulation Reduces Risk of Post-ERCP Pancreatitis and Facilitates Bile Duct Cannulation / L. A. Everson, P. Sakai [et al.] // American Journal of Gastroenterology. – 2007. – Vol. 102. – Р. 2147–2153.
27. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP / R. Sotoudehmanesh, M. Khatibian, S. Kolahdoozan [et al.] // Am. J. Gastroenterol. – 2007. – Vol. 102. – Р. 978–983.
28. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures : a randomised controlled trial / Poon R.T., Yeung C., Liu C.L. et al. // Gut. – 2003. – Vol. 52. – Р. 1768–1773.
29. Kwanngern K. Can a single dose corticosteroid reduce the incidence of post-ERCP pancreatitis? A randomized, prospective control study / K. Kwanngern, P. Tiyapattanaputi, M. Wanitpukdeedecha // J. Med. Assoc. Thai. – 2005. – Vol. 88. – Suppl.4. – S. 42–45.
30. Lazaraki G. Prevention of post ERCP pancreatitis : an overview / G. Lazaraki, P. Katsinelos // Annals of gastroenterology. – 2008. – Vol. 21, No 1. – Р. 27–38.
31. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis / Rabenstein T., Fischer B., Wiessner V. [et al.] // Gastrointest Endosc. – 2004. – Vol. 59. – Р. 606–613.
32. Natural beta-carotene for the prevention of post-ERCP pancreatitis / Lavy A., Karban A., Suissa A. et al. // Pancreas. – 2004. – Vol. 29. – Р. e45–e50.
33. Nifedipine for prevention of post-ERCP pancreatitis : a prospective, double-blind randomized study / F. Prat, J. Amaris, B. Ducot [et al.] // Gastrointest. Endosc. – 2002. – Vol. 56. – Р. 202–208.
34. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial / Manolakopoulos S., Avgerinos A., Vlachogiannakos J. [et al.] // Gastrointest Endosc. – 2002. – Vol. 55. – Р. 470–475.
35. Pharmacologic treatment can prevent pancreatic injury after ERCP : a meta-analysis / Andriulli A., Leandro G., Niro G. [et al.] // Gastrointest Endosc. – 2000. – Vol. 51. – Р. 1–7.
36. Pharmacologic treatment can prevent pancreatic injury after ERCP : a meta-analysis / Andriulli A., Leandro G., Niro G. et al. // Gastrointest Endosc. – 2000. – Vol. 51. – Р. 1–7.
37. Post-ERCP pancreatitis: reduction by routine antibiotics / S. Räty, J. Sand, M. Pulkkinen [et al.] // J. Gastrointest. Surg. – 2001. – Vol. 5. – Р. 339–345.
38. Predictors of post-ERCP complications in patients with suspected choledocholithiasis / S. N. Mehta, E. Pavone, J. S. Barkun [et al.] // Endoscopy. – 1998. – Vol. 30. – Р. 457–463.
39. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial / J. A. Dumot, D. L. Conwell, J. B. O’Connor [et al.] // Am. J. Gastroenterol. – 1998. – Vol. 93. – Р. 61–65.
40. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis / Andriulli A., Leandro G., Federici T. [et al.] // Gastrointest Endosc. – 2007. – Vol. 65. – Р. 624–632.
41. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis / Andriulli A., Leandro G., Federici T. [et al.] // Gastrointest Endosc. – 2007. – Vol. 65. – Р. 624–632.
42. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP : effects on technical success and post-ERCP pancreatitis / A. J. Kaffes, M. J. Bourke, S. Ding [et al.] // Gastrointest Endosc. – 2006. – Vol. 64. – Р. 351–357.
43. Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure / K. Ito, N. Fujita, Y. Noda [et al.] // World J. Gastroenterol. – 2007. – Vol. 13. – Р. 3855–3860.
44. Risk factors for post-ERCP pancreatitis : a prospective multicenter study / Am. J. Gastroenterol. – 2006. – Vol. 101. – Р.139–147.
45. Risk factors for post-ERCP pancreatitis : a prospective, multicenter study / M. L. Freeman, J. A. DiSario, D. B. Nelson [et al.] // Gastrointest. Endosc. – 2001. – Vol. 54. – Р. 425–434.
46. Risk factors for post-ERCP pancreatitis : a prospective, multicenter study / M. L. Freeman, J. A. DiSario, D. B. Nelson [et al.] // Gastrointest. Endosc. – 2001. – Vol. 54. – Р. 425–434.
47. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis / M. Khoshbaten, H. Khorram, L. Madad [et al.] // J Gastroenterol Hepatol. – 2008. – Vol. 23. – Р. 11–16.
48. Sand J. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography / Sand J., Nordback I. // Digestion. – 1993. – Vol. 54. – Р. 179–184.
49. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis / P. A. Testoni, F. Bagnolo, S. Caporuscio, F. Lella // Am. J. Gastroenterol. – 1999. – Vol. 94. – Р. 1235–1241.
50. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention : meta-analysis of randomized placebo-controlled trials / Rudin D., Kiss A., Wetz R.V. [et al.] // J Gastroenterol Hepatol. – 2007. – Vol. 22. – Р. 977–983.
51. Sudhindran S. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis / S. Sudhindran, E. Bromwich, P. R. Edwards // Br. J. Surg. – 2001. – Vol. 88. – Р. 1178–1182.
52. The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis / Schwartz J.J., Lew R.J., Ahmad N.A. [et al.] // Gastrointest Endosc. – 2004. – Vol. 59. – Р. 179–184.
53. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis : a randomized double-blind trial / M. Moretó, M. Zaballa, I. Casado [et al.] // Gastrointest. Endosc. – 2003. – Vol. 57. – Р.1-7.
54. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis / Thomopoulos K.C., Pagoni N.A., Vagenas K.A. [et al.] // Gastrointest Endosc. – 2006. – Vol. 64. – Р. 726–731.
55. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography : a randomized, controlled trial / Tsujino T., Komatsu Y., Isayama H. [et al.] // Clin Gastroenterol Hepatol. – 2005. – Vol. 3. – Р. 376–383.
56. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study / Fujishiro H., Adachi K., Imaoka T. [et al.] // J Gastroenterol Hepatol. – 2006. – Vol. 21. – Р. 1065–1069.
57. Use of corticosteroids in the prevention of post-ERCP pancreatitis / G. R. Wiener, J. E. Geenen, W. J. Hogan [et al.] // Gastrointest. Endosc. – 1995. – Vol. 42. – Р. 579–583.
58. Utility of bolus somatostatin administration in preventing pancreatitis after endoscopic retrograde cholangiopancreatography : a controlled, non-randomized study / Vila J.J., Jiménez F.J., Prieto C. [et al.] // Gastroenterol Hepatol. – 2006. – Vol. 29. – Р. 231–236.
2. Ильченко А. А. Желчнокаменная болезнь / А. А. Ильченко. – М. :Анахарсис, 2004. – 200 с.
3. Ильченко А. А. Эндоскопическая ретроградная холангиопанкреатико-графия: возможна ли эффективная профилактика ЭРХПГ-индуцированного панкреатита / А. А. Ильченко// Экспериментальная и клиническая гастроэнтерология. – 2008. – № 3. – С. 62–71.
4. Лосев С. В. Применение «Oктреотида» для профилактики панкреатита при проведении ЭРХПГ [Электронный ресурс] / С. В. Лосев, В. В. Феденко. – Электрон. текстовые дан. – Режим доступа: http://octreotide.Pharm-sintez.ru/issue/octr107.htm.
5. Манцеров М. П. Реактивный панкреатит после эндоскопических манипуляций на большом дуоденальном сосочке / Манцеров М. П., Мороз Е. В. // Рос. журн. Гастроэнтерол., гепатол., колопроктол. – 2007. – Т. XVII, № 3. – С. 14–23.
6. Ханевич М. Д. Транспапиллярные методы лечения механической желтухи / М. Д. Ханевич, А. М. Гробовый // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. – 2005. – № 3. – С. 57–61.
7. Эндоскопическая ретроградная холангиопанкреатография. Стандарт проведения / Щербаков П. Л., Парфенов А. И., Ильченко А. А. [и др.] // Экспериментальная и клиническая гастроэнтерология. – 2009. – № 3. – С. 150–155.
8. Banks P. A. Practice Parameters Committee of the American College of Gastroenterology. Practice Guidelines in Acute Pancreatitis / P. A. Banks, M. L. Freeman // Am. J. Gastroenterol. – 2006. – Vo. 101. – Р. 2379–2400.
9. Banks P. A. Practice Parameters Committee of the American College of Gastroenterology. Practice Guidelines in Acute Pancreatitis / P. A. Banks, M. L. Freeman // Am. J. Gastroenterol. – 2006. – Vol. 101. – Р. 2379–2400.
10. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial / Arvanitidis D., Anagnostopoulos G.K., Giannopoulos D. [et al.] // J Gastroenterol Hepatol. – 2004. – Vol. 19. – Р. 278–282.
11. Chen S.Y. Ulinastatin in the treatment of acute pancreatitis : a multicenter clinical trial / Chen S.Y., Wang J.Y. // Chin J Dig Dis. – 2002. – Vol. 3. – Р. 70–75.
12. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis : a prospective, randomized trial / Ueki T., Otani K., Kawamoto K. [et al.] // J Gastroenterol. – 2007. – Vol. 42. – Р. 161–167.
13. Complications of endoscopic sphincterotomy: Can heparin prevent acute pancreatitis after ERCP? / Rabenstein T., Roggenbuck S., Framke B. [et al.] // Gastrointest Endosc. – 2002. – Vol. 55. – Р. 476–483.
14. Complications of ERCP by the American Society for Gastrointestinal Endoscopy // Gastrointestinal Endoscopy. – 2012. – Vol. 75, No 3. – Р. 467–472.
15. De Palma G. D. Use of corticosteriods in the prevention of post-ERCP pancreatitis : results of a controlled prospective study / G. D. De Palma, C. Catanzano // Am. J. Gastroenterol. – 1999. – Vol. 94. – Р. 982-5.
16. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography / B. Murray, R. Carter, C. Imrie [et al.] // Gastroenterology. – 2003. – Vol. 124. – Р. 1786–1791.
17. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis : a randomized, prospective, multicenter study / S. Sherman, U. Blaut, J. L. Watkins [et al.] // Gastrointest Endosc. – 2003. – Vol. 58. – Р. 23–29.
18. Donnellan F. Prevention of Post-ERCP Pancreatitis / F. Donnellan, M. F. Byrne. // Gastroenterology Research and Practice. – 2012. – Article ID 796751. – 12 p.
19. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes / K. Gottlieb, S. Sherman, J. Pezzi [et al.] // Am. J. Gastroenterol. – 1996. – Vol. 91. – Р. 1553–1561.
20. Effect of calcitonin on the serum amylase levels after endoscopic retrograde cholangiopancreatography / Odes H.S., Novis B.N., Barbezat G.O., Bank S. // Digestion. – 1977. – Vol. 16. – Р. 180–184.
21. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia : a multicenter, placebo-controlled, randomized clinical trial / Li Z.S., Pan X., Zhang W.J. [et al.] // Am J Gastroenterol. – 2006. – Vol. 102. – Р. 46–51.
22. Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis / Messori A., Rampazzo R., Scroccaro G. [et al.] // Dig Dis Sci. – 1995. – Vol. 40. – Р. 734–738.
23. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique / E. Elton, D. A. Howell, W. G. Parsons [et al.] // Gastrointest. Endosc. – 1998. – Vol. 47. – Р. 240–249.
24. Freeman M. L. Prevention of post-ERCP pancreatitis : a comprehensive review / M. L. Freeman, N. M. Guda // Gastrointest Endosc. – 2004. – Vol. 59. – Р. 845–864.
25. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group / Cavallini G., Tittobello A., Frulloni L. [et al.] // N Engl J Med. – 1996. – Vol. 335. – Р. 919–923.
26. Guidewire Cannulation Reduces Risk of Post-ERCP Pancreatitis and Facilitates Bile Duct Cannulation / L. A. Everson, P. Sakai [et al.] // American Journal of Gastroenterology. – 2007. – Vol. 102. – Р. 2147–2153.
27. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP / R. Sotoudehmanesh, M. Khatibian, S. Kolahdoozan [et al.] // Am. J. Gastroenterol. – 2007. – Vol. 102. – Р. 978–983.
28. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures : a randomised controlled trial / Poon R.T., Yeung C., Liu C.L. et al. // Gut. – 2003. – Vol. 52. – Р. 1768–1773.
29. Kwanngern K. Can a single dose corticosteroid reduce the incidence of post-ERCP pancreatitis? A randomized, prospective control study / K. Kwanngern, P. Tiyapattanaputi, M. Wanitpukdeedecha // J. Med. Assoc. Thai. – 2005. – Vol. 88. – Suppl.4. – S. 42–45.
30. Lazaraki G. Prevention of post ERCP pancreatitis : an overview / G. Lazaraki, P. Katsinelos // Annals of gastroenterology. – 2008. – Vol. 21, No 1. – Р. 27–38.
31. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis / Rabenstein T., Fischer B., Wiessner V. [et al.] // Gastrointest Endosc. – 2004. – Vol. 59. – Р. 606–613.
32. Natural beta-carotene for the prevention of post-ERCP pancreatitis / Lavy A., Karban A., Suissa A. et al. // Pancreas. – 2004. – Vol. 29. – Р. e45–e50.
33. Nifedipine for prevention of post-ERCP pancreatitis : a prospective, double-blind randomized study / F. Prat, J. Amaris, B. Ducot [et al.] // Gastrointest. Endosc. – 2002. – Vol. 56. – Р. 202–208.
34. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial / Manolakopoulos S., Avgerinos A., Vlachogiannakos J. [et al.] // Gastrointest Endosc. – 2002. – Vol. 55. – Р. 470–475.
35. Pharmacologic treatment can prevent pancreatic injury after ERCP : a meta-analysis / Andriulli A., Leandro G., Niro G. [et al.] // Gastrointest Endosc. – 2000. – Vol. 51. – Р. 1–7.
36. Pharmacologic treatment can prevent pancreatic injury after ERCP : a meta-analysis / Andriulli A., Leandro G., Niro G. et al. // Gastrointest Endosc. – 2000. – Vol. 51. – Р. 1–7.
37. Post-ERCP pancreatitis: reduction by routine antibiotics / S. Räty, J. Sand, M. Pulkkinen [et al.] // J. Gastrointest. Surg. – 2001. – Vol. 5. – Р. 339–345.
38. Predictors of post-ERCP complications in patients with suspected choledocholithiasis / S. N. Mehta, E. Pavone, J. S. Barkun [et al.] // Endoscopy. – 1998. – Vol. 30. – Р. 457–463.
39. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial / J. A. Dumot, D. L. Conwell, J. B. O’Connor [et al.] // Am. J. Gastroenterol. – 1998. – Vol. 93. – Р. 61–65.
40. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis / Andriulli A., Leandro G., Federici T. [et al.] // Gastrointest Endosc. – 2007. – Vol. 65. – Р. 624–632.
41. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis / Andriulli A., Leandro G., Federici T. [et al.] // Gastrointest Endosc. – 2007. – Vol. 65. – Р. 624–632.
42. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP : effects on technical success and post-ERCP pancreatitis / A. J. Kaffes, M. J. Bourke, S. Ding [et al.] // Gastrointest Endosc. – 2006. – Vol. 64. – Р. 351–357.
43. Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure / K. Ito, N. Fujita, Y. Noda [et al.] // World J. Gastroenterol. – 2007. – Vol. 13. – Р. 3855–3860.
44. Risk factors for post-ERCP pancreatitis : a prospective multicenter study / Am. J. Gastroenterol. – 2006. – Vol. 101. – Р.139–147.
45. Risk factors for post-ERCP pancreatitis : a prospective, multicenter study / M. L. Freeman, J. A. DiSario, D. B. Nelson [et al.] // Gastrointest. Endosc. – 2001. – Vol. 54. – Р. 425–434.
46. Risk factors for post-ERCP pancreatitis : a prospective, multicenter study / M. L. Freeman, J. A. DiSario, D. B. Nelson [et al.] // Gastrointest. Endosc. – 2001. – Vol. 54. – Р. 425–434.
47. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis / M. Khoshbaten, H. Khorram, L. Madad [et al.] // J Gastroenterol Hepatol. – 2008. – Vol. 23. – Р. 11–16.
48. Sand J. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography / Sand J., Nordback I. // Digestion. – 1993. – Vol. 54. – Р. 179–184.
49. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis / P. A. Testoni, F. Bagnolo, S. Caporuscio, F. Lella // Am. J. Gastroenterol. – 1999. – Vol. 94. – Р. 1235–1241.
50. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention : meta-analysis of randomized placebo-controlled trials / Rudin D., Kiss A., Wetz R.V. [et al.] // J Gastroenterol Hepatol. – 2007. – Vol. 22. – Р. 977–983.
51. Sudhindran S. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis / S. Sudhindran, E. Bromwich, P. R. Edwards // Br. J. Surg. – 2001. – Vol. 88. – Р. 1178–1182.
52. The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis / Schwartz J.J., Lew R.J., Ahmad N.A. [et al.] // Gastrointest Endosc. – 2004. – Vol. 59. – Р. 179–184.
53. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis : a randomized double-blind trial / M. Moretó, M. Zaballa, I. Casado [et al.] // Gastrointest. Endosc. – 2003. – Vol. 57. – Р.1-7.
54. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis / Thomopoulos K.C., Pagoni N.A., Vagenas K.A. [et al.] // Gastrointest Endosc. – 2006. – Vol. 64. – Р. 726–731.
55. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography : a randomized, controlled trial / Tsujino T., Komatsu Y., Isayama H. [et al.] // Clin Gastroenterol Hepatol. – 2005. – Vol. 3. – Р. 376–383.
56. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study / Fujishiro H., Adachi K., Imaoka T. [et al.] // J Gastroenterol Hepatol. – 2006. – Vol. 21. – Р. 1065–1069.
57. Use of corticosteroids in the prevention of post-ERCP pancreatitis / G. R. Wiener, J. E. Geenen, W. J. Hogan [et al.] // Gastrointest. Endosc. – 1995. – Vol. 42. – Р. 579–583.
58. Utility of bolus somatostatin administration in preventing pancreatitis after endoscopic retrograde cholangiopancreatography : a controlled, non-randomized study / Vila J.J., Jiménez F.J., Prieto C. [et al.] // Gastroenterol Hepatol. – 2006. – Vol. 29. – Р. 231–236.